Navigation Links
Is Chronic Pain Keeping You Awake? Help Is On the Way

WALTHAM, Mass., Oct. 22, 2013 /PRNewswire/ -- According to some studies, more than 100 million people in North America live with—or perhaps more accurately, don't find it easy to live with—days and nights filled with chronic pain. They know that persistent pain does more than make one achy and perhaps a bit cranky. Chronic pain has been associated with a significant increase in the rate of depression and anxiety. Most of those who have to endure chronic pain may also have problems with attention, memory, high blood pressure and related heart problems, along with sleep issues. Common causes of pain include degenerative spine disease, lower back pain, rheumatoid arthritis, osteoarthritis, fibromyalgia, HIV, migraine, neuropathy and complications of shingles.

This population includes approximately five million people with Type 2 diabetes who experience chronic pain, a condition called painful diabetic neuropathy (PDN). It is estimated that about half of them suffer pain that keeps them from getting to sleep, or when they do, staying asleep.   

Neuropathy in Type 2 diabetes can frustrate both patients and their doctors and other health providers. Although there is a range of treatments, including pharmaceutical painkillers, antidepressants, anticonvulsants, steroid and cortisone injections, analgesic patches, vitamin B shots and hot/cold packs, relief is often elusive or sporadic. People with chronic pain may need a deep, restorative night's rest to fully function.  

The good news is that there has been a major advance for PDN: the SENSUS Pain Management System. SENSUS has been developed by NeuroMetrix Inc., a medical device company in Waltham, Massachusetts. SENSUS offers transcutaneous electrical nerve stimulation and is the first device of its kind to receive 510(k) clearance from the U.S. Food and Drug Administration for use during sleep. SENSUS is lightweight, made to be worn under clothing, and offers non-narcotic pain relief as a complement to medications. It has an easy-to-use one-button control.

"At one time or another we all suffer from some level of pain. It is usually brief. Chronic pain is entirely different," says Shai N. Gozani, M.D., Ph.D., the President and CEO of NeuroMetrix. "It can result in sleep deprivation and interfere with relationships, work and overall well-being. We believe the SENSUS Pain Management System can make a difference to patients suffering from chronic pain, including PDN."

For more on SENSUS, visit or ask your doctor.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chronic Use of Prescription Painkillers Continues Following Bariatric Surgery
2. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
3. Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets
4. arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7
5. Olodaterol Shows Sustained Improvements in Lung Function in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
6. Newly-Published Study Concludes Stretta May Be More Desirable GERD Treatment than Chronic PPI Use or Anti-Reflux Surgery in Some Patients
7. SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
8. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
9. Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
10. Abuse-Deterrent Formulations of Purdues OxyContin and Endo Pharmaceuticals Opana ER Have Not Increased PCPs Comfort When Prescribing These Products for Chronic Pain
11. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):